| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.77▼ | 4.75▲ | 4.73▲ | 4.60▲ | 4.38▲ |
| MA10 | 4.75▲ | 4.69▲ | 4.65▲ | 4.44▲ | 3.50▲ |
| MA20 | 4.64▲ | 4.66▲ | 4.62▲ | 4.40▲ | 3.12▲ |
| MA50 | 4.61▲ | 4.58▲ | 4.57▲ | 3.32▲ | N/A |
| MA100 | 4.56▲ | 4.41▲ | 4.44▲ | 3.15▲ | N/A |
| MA200 | 4.53▲ | 4.41▲ | 3.75▲ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.016▲ | 0.012▲ | 0.010▲ | -0.019▼ | N/A |
| RSI | 60.586▲ | 58.027▲ | 58.201▲ | 61.127▲ | 44.714▼ |
| STOCH | 88.933▲ | 93.886▲ | 69.361 | 59.596 | 53.780 |
| WILL %R | -12.903▲ | -12.121▲ | -17.778▲ | -29.201 | -48.633 |
| CCI | 74.052 | 101.967▲ | 84.559 | 59.484 | 113.306▲ |
| MA | $KLRS Price Crossed Above MA(7) | Set Alert |
|
Monday, September 15, 2025 12:50 PM
Recently initiated Phase 1b/2 multiple ascending dose study intended to assess safety and efficacy in nAMD patients receiving four initial monthly doses of TH103 Phase 1b/2 study to inform dose ...
|
|
Wednesday, September 03, 2025 11:21 PM
Fintel reports that on September 3, 2025, Raymond James initiated coverage of Kalaris Therapeutics (NasdaqGM:KLRS) with a Strong Buy recommendation. Analyst Price Forecast Suggests 158.37% Upside As ...
|
|
Wednesday, September 03, 2025 07:42 AM
Kalaris Therapeutics Inc. (KLRS) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 25/09/25 | 4.53 | 4.81 | 4.41 | 4.77 | 80,754 |
| 24/09/25 | 4.79 | 4.93 | 4.45 | 4.53 | 139,100 |
| 23/09/25 | 4.43 | 4.82 | 4.40 | 4.77 | 142,722 |
| 22/09/25 | 4.52 | 4.90 | 4.325 | 4.40 | 215,000 |
| 19/09/25 | 4.38 | 4.80 | 4.25 | 4.54 | 234,211 |
| 18/09/25 | 4.45 | 4.533 | 4.15 | 4.39 | 148,900 |
| 17/09/25 | 4.98 | 5.30 | 4.361 | 4.44 | 353,200 |
| 16/09/25 | 3.91 | 5.15 | 3.7501 | 5.01 | 415,433 |
| 15/09/25 | 3.76 | 3.9621 | 3.485 | 3.71 | 166,559 |
| 12/09/25 | 4.17 | 4.175 | 3.81 | 3.89 | 214,200 |
|
|
||||
|
|
||||
|
|